The HMG Co-A reductase inhibitors ('statins') and myotoxic effects

被引：0
|
作者：
机构：
[1] Med Control Council, Natl Adverse Drug Event Monitoring Ctr, Cape Town, South Africa
来源：
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2002年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 50 条
  • [1] Can HMG Co-A reductase inhibitors ("statins") slow the progression of AMD?
    Guymer, RH
    Robman, L
    Varsamidis, M
    Dimitrov, P
    Hunt, N
    Lim, L
    Vingrys, A
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [2] EFFECTS OF HMG CO-A REDUCTASE INHIBITORS ON LIPIDS AND LIPOPROTEIN(A) IN HYPERCHOLESTEROLEMIA
    OCONNOR, P
    COOKE, T
    FEELY, J
    [J]. DRUG INVESTIGATION, 1992, 4 (03): : 227 - 231
  • [3] VALIDATION OF HPLC METHOD FOR DETERMINATION OF HMG CO-A REDUCTASE INHIBITORS
    Manova, M.
    Pencheva, I.
    Peikov, P.
    Petrova, G.
    Tsvetkova, B.
    [J]. PHARMACIA, 2011, 58 (1-4) : 50 - 54
  • [4] Comparative HMG co-a reductase inhibitors (CHRIS) substudy on fibrinogen
    Rosenson, RS
    Tangney, CC
    Schaefer, EJ
    [J]. CIRCULATION, 1999, 100 (18) : 825 - 825
  • [5] HMG CO-A REDUCTASE INHIBITORS, NSAIDS, PHARMACOGENETICS, AND RISK OF GLIOMA
    Lai, Rose K.
    Ferris, Jennifer
    Florendo, Erika
    McCoy, Lucie
    Rice, Terri
    Ottman, Ruth
    Neugut, Alfred I.
    Wiencke, John
    Wiemels, Joe
    Wrensch, Margaret
    [J]. NEURO-ONCOLOGY, 2010, 12 : 28 - 28
  • [6] HYPOMETHYLATION OF HMG CO-A REDUCTASE GENE (HMG CO-A RG) IN HUMAN COLON CARCINOGENESIS
    VASUDEVAN, S
    KHANDELWAL, M
    AKERMAN, PA
    JONES, WF
    RAO, PM
    RAJALAKSHMI, S
    MARCON, NE
    SARMA, DSR
    [J]. GASTROENTEROLOGY, 1994, 106 (04) : A448 - A448
  • [7] Colchicine and HMG Co-A reductase inhibitors induced myopathy - A case report
    Torgovnick, Josh
    Sethi, Nitin
    Arsura, Edward
    [J]. NEUROTOXICOLOGY, 2006, 27 (06) : 1126 - 1127
  • [8] HMG Co-A reductase inhibitors improve renal hemodynamics and function in renal ischemia
    Chade, AR
    Krier, JD
    Lerman, A
    Lerman, LO
    [J]. CIRCULATION, 2004, 110 (17) : 313 - 313
  • [9] Do hyperlipidemic patients with elevated baseline liver enzymes have a higher risk of hepatotoxicity from HMG Co-A reductase inhibitors (statins)?
    Chalasani, N
    Liangpunsakul, S
    Murray, M
    Kesterson, J
    Hall, SD
    [J]. HEPATOLOGY, 2003, 38 (04) : 697A - 697A
  • [10] The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice
    Khong, TK
    Missouris, CG
    Murda'h, M
    MacGregor, GA
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1998, 74 (876) : 600 - 601
12345